Gastrointestinal Stromal Tumor: Ripretinib vs Sunitinib

We are comparing two treatments for advanced gastrointestinal stromal tumors in patients with specific genetic mutations who have been treated before. The goal is to find out which medication may help control the disease better and improve quality of life.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Qinlock
Qinlock is a cancer medicine used to treat certain tumors in the stomach or intestines called gastrointestinal stromal tumors.
Sunitinib Aqvida
Sunitinib Aqvida is a cancer medicine used to treat certain tumors, including advanced kidney and some digestive system cancers.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ripretinib
Ripretinib is a substance that blocks proteins that help certain cancer cells grow and is used to treat advanced gastrointestinal stromal tumors.
Sunitinib
Sunitinib is a cancer-targeting substance that helps block tumor growth and reduce formation of blood vessels feeding certain tumors.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Egotux
Klertis
Lusmose

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Oncologie option médicale
Bordeaux, France
Centre Leon Berard
Oncologie option médicale
Meyzieu, France
Centre De Lutte Contre Le Cancer Eugene Marquis
Oncologie option médicale
Rennes, France

Sponsor: Deciphera Pharmaceuticals Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.